It's all about the experience. Everything we do is about simplifying and making things better and easier. It's about making a difference in people's lives.
Meet Xeris Pharmaceuticals
Xeris is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables.Come see what we're about
Our team is focused on creating medicines that are easier to use by leveraging our unique technology. Gvoke®(glucagon injection) leverages that technology to deliver ready-to-use solutions for patients and caregivers alike.View our new offerings
Severe hypoglycemia and epilepsy are both conditions that can require rapid medical attention yet have complicated processes to administer treatment. We're ready to change that.Discover how we can help
Supporting independent medical education, contributing to advancements in medical and scientific research, and supporting initiatives that enhance both patient experiences and the diabetes care community.Learn More
We're people people. We've handpicked our team to ensure each individual's strengths further the pursuit of our shared goal to change patients' lives.Get to know us
We are proud to announce that as of October 5, 2021,
Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc
are subsidiaries of Xeris Biopharma Holdings, Inc.
Not opening? Check to see you have pop-ups enabled or copy link below in a new window.https://ir.xerispharma.com/